Delivery Order SPE2DB22D9112-SPE2DB25FTKPF
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,522.17 for MENVEO Vaccine VL 5S under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program. The award is firm fixed price with no set-aside designation, and the ultimate completion date is July 31, 2025. This delivery order represents one of numerous pharmaceutical product orders issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.55 to DMS Pharmaceutical Group Inc. for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, was executed without a set-aside designation. The award represents a standard transactional order under DMS Pharmaceutical Group's broader pharmaceutical supply contract with DLA, fulfilling the...
- This is a $1,080.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the MENVEO VACCINE VL 5S medical product, with an ultimate completion date of June 17, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price purchase order valued at $41,795.96 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The contract, designated as a Total Small Business set-aside, covers the supply of meningococcal group vaccines and related pharmaceutical products. The award was issued rapidly following a solicitation posted on July 15, 2025, with a...
- Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a $6,236.64 firm fixed price delivery order to supply one vial of MENVEO, a meningococcal vaccine. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with Defense Logistics Agency to provide various pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $25,942.32 for the supply of Menveo A-C-Y-W immunization kits. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,676.34, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of May 8, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W vaccines, with a ceiling value of $3,603.10 and a period of performance through April 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
- This delivery order awards $2,075.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine product. The Defense Logistics Agency issued this firm fixed-price delivery order on July 25, 2025, with an ultimate completion date of July 28, 2025. The award carries no set-aside designation, and performance will occur at the contractor's Park Ridge, Illinois location. This...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,628 contract is for the delivery of meningococcal group vaccines and medical supplies, with a period of performance through June 2025. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB25FTKPFDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,441.24 by the Defense Logistics Agency on July 30, 2025. The delivery order is for MENVEO A-C-Y-W Kit (2 Vials), a meningococcal vaccine product, with an ultimate completion date of July 31, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal marketplace. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, administered under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. As a established supplier within the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has consistently secured contracts across diverse product categories including vaccines, injections, prescription medications, biologics, and medical consumables for military health system operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/30/25 |